NYSE:DVAHealthcare
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story?
In the past quarter, DaVita Inc. reported Q2 2026 revenue of US$3,554.08 million and net income of US$265.4 million, with diluted EPS from continuing operations rising to US$4.02 from US$2.58 a year earlier.
Beyond the headline growth, DaVita paired higher earnings with improved patient mortality, stronger treatment volumes, and an accelerated rollout of advanced hemodialysis dialyzers following recent FDA approvals.
We'll now examine how DaVita's improved mortality trends and expanding...